Thus, it can be assumed that the decrease of claudin-5 level occurs before the onset of damage to the heart, and that the stable expression of claudin-5 in the mouse model prevents the occurrence of cardiomyopathy. This evidence concerns the gene CLDN5 and cardiomyopathy.